Parallax Volatility Advisers
IRWD icon

Parallax Volatility Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Parallax Volatility Advisers’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50,626
Closed -$573K – 3162
2019
Q1 		$573K Buy
50,626
+20,776
+70% +$232K ﹤0.01% 1480
2018
Q4 		$259K Buy
+29,850
New +$343K ﹤0.01% 1676
2017
Q1 		– Sell
-59,700
Closed -$765K – 4102
2016
Q4 		$765K Buy
+59,700
New +$754K ﹤0.01% 1341

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Parallax Volatility Advisers's IRWD Position: Q2 2024 in Review

Parallax Volatility Advisers sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 64 shares — an estimated $557 sold.

Parallax Volatility Advisers first reported a position in IRWD in Q3 2017 and held it in 7 quarters. The position peaked at $3.47M in Q3 2018. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • Parallax Volatility Advisers reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 64 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $557.
  • Parallax Volatility Advisers first reported a position in Ironwood Pharmaceuticals in Q3 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's Ironwood Pharmaceuticals position peaked at $3.47M in Q3 2018.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Parallax Volatility Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.